Accsys (AXS): Tricoya consortium structure completed (BUY) | HML Holdings* (HMLH): Acquisition and upgrade (CORP) | Cambridge Cognition* (COG): Old COG with some cool new tricks (CORP) | Transense Technologies* (TRT): Interim results, further payment from GE (CORP) | Hardide* (HDD): Hardide gains Airbus global supplier status approval (CORP) | Omega Diagnostics* (ODX): Regulatory clearance for Malaria test (CORP) | Allergy Therapeutics (AGY): Interims demonstrate strong momentum (BUY)
29 Mar 2017
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
29 Mar 2017 -
Author:
David Buxton | Mark Paddon | Mark Brewer | Cavendish Research -
Pages:
9
Accsys (AXS): Tricoya consortium structure completed (BUY) | HML Holdings* (HMLH): Acquisition and upgrade (CORP) | Cambridge Cognition* (COG): Old COG with some cool new tricks (CORP) | Transense Technologies* (TRT): Interim results, further payment from GE (CORP) | Hardide* (HDD): Hardide gains Airbus global supplier status approval (CORP) | Omega Diagnostics* (ODX): Regulatory clearance for Malaria test (CORP) | Allergy Therapeutics (AGY): Interims demonstrate strong momentum (BUY)